Pathophysiology of Renal and Genitourinary Disorders

Normal Kidney Function and Renal Anatomy

  • Primary Functions of the Kidney

    • Filtration and Excretion: Filters the blood to produce urine, removing metabolic waste products while reabsorbing essential nutrients.

    • Homeostasis: Maintains fluid balance, electrolyte balance, and acid-base balance (H+H^+ and bicarbonate).

    • Blood Pressure Regulation: Controlled through the Renin-Angiotensin-Aldosterone System (RAAS) and fluid volume management.

    • Endocrine Functions:

      • Erythropoietin (EPO) Production: Stimulates red blood cell production in the bone marrow.

      • Bone Health: Involved in the activation of Vitamin D, which is essential for calcium absorption.

  • The Nephron: The Functional Unit

    • Renal Corpuscle: Consists of the Glomerulus (the capillary network) and Bowman’s Capsule (receives the filtrate).

    • Tubular System:

      • Proximal Convoluted Tubule (PCT): Responsible for the reabsorption of all nutrients and necessary solutes (the "stuff" we want to keep).

      • Nephron Loop (Loop of Henle): Critical for concentrating the tubular fluid.

      • Distal Convoluted Tubule (DCT) and Collecting Duct (CD): Areas used to maintain homeostasis through hormonal regulation, specifically Antidiuretic Hormone (ADH) and Aldosterone.

    • Anatomy of Drainage: The collecting ducts drain into the minor and major calyces, then into the renal pelvis, followed by the ureters, and finally the bladder for storage.

  • Glomerular Filtration Mechanics

    • Permeability: Factors like Albumin and cellular components (Red Blood Cells) should ideally remain in the blood and not be filtered.

    • Filtrate Components: Glucose, electrolytes, Blood Urea Nitrogen (BUN), Creatinine, and Hydrogen ions (H+H^+) are freely filtered.

    • Podocytes: Specialized cells that regulate the filtration process at the glomerular level.

    • Glomerular Filtration Rate (GFR):

      • The normal GFR is approximately 90−120 mL/min90-120\,mL/min.

      • The kidneys receive approximately 20%−25%20\%-25\% of the total Cardiac Output (CO), which equals 600−720 mL600-720\,mL per minute.

      • eGFR: GFR is estimated using serum Creatinine levels.

      • Normal Serum Creatinine: Approximately 0.6−1.2 mg/dL0.6-1.2\,mg/dL for men and 0.5−1.1 mg/dL0.5-1.1\,mg/dL for women.

Glomerular and Immune-Mediated Diseases

  • Glomerulonephritis (GN)

    • Definition: A group of renal diseases involving inflammation and damage to the glomerulus.

    • Etiology: The vast majority of these diseases are autoimmune or immune-mediated.

    • Significance: Approximately 25%−30%25\%-30\% of all End-Stage Renal Disease (ESRD) cases result from Glomerulonephritis.

  • Nephritic Syndrome (Pattern)

    • Pathophysiology: Characterized by inflammation that damages the glomerular basement membrane (GBM), disrupting its ability to selectively filter solutes.

    • Etiologies:

      • Post-Infectious: e.g., post-streptococcal glomerulonephritis.

      • Autoimmune: IgA Nephropathy (also known as Berger Disease).

    • Signs and Symptoms:

      • Edema: Most often periorbital (around the eyes) and pedal (in the feet).

      • Hematuria: Presence of blood in the urine, often described as "Coca-Cola-colored."

      • Proteinuria: Present but less severe, typically < 3.5\,g/day.

      • Hypertension: New onset high blood pressure.

      • Renal Insufficiency: Decreased GFR leading to Oliguria (low urine output) and Azotemia (accumulation of nitrogenous waste in the blood).

  • Nephrotic Syndrome (Pattern)

    • Pathophysiology: Minimal inflammation is present. The damage is primarily to the podocytes, which allows excessive amounts of protein to leak into the filtrate.

    • Etiologies:

      • Primary: e.g., Minimal-change disease.

      • Secondary: Can be a results of Lupus or Diabetes.

    • Signs and Symptoms:

      • Swelling of the face: Often the first symptom noted.

      • Anasarca: Profound generalized edema.

      • Frothy Urine: Caused by massive proteinuria (> 3.5\,g/day).

      • Hypercholesterolemia: Elevated cholesterol levels.

      • Hypoalbuminemia: Significant drop in serum albumin due to loss in urine.

      • Systemic Effects: Fatigue and loss of appetite.

  • Comparison: Nephrotic vs. Nephritic

    • Hematuria: Negative in Nephrotic; Positive in Nephritic.

    • RBC Casts: Negative in Nephrotic; Positive in Nephritic.

    • Hypertension: Negative in Nephrotic; Positive in Nephritic.

    • Edema: ++++++++ (profound) in Nephrotic; ++++ (moderate) in Nephritic.

    • Oliguria: ++ (mild) in Nephrotic; ++++++++ (severe) in Nephritic.

    • Fatty Casts: Positive in Nephrotic; Negative in Nephritic.

    • Proteinuria: Severe (> 3.5\,g/day) in Nephrotic; Mild (< 3.5\,g/day) in Nephritic.

Infection and Inflammation

  • Cystitis (Bladder Infection)

    • Etiology: Most commonly caused by E. coli (90%90\% of cases).

    • Pathogenesis: Bacteria colonize the urethral opening and ascend into the bladder. E. coli possess fimbriae, which allow them to grab onto the urinary tract and climb against the flow of urine.

    • Risk Factors:

      • Females (shorter urethra).

      • Hygiene (improper wiping technique).

      • Sexual activity (mechanical pushing of bacteria upward).

      • Stagnant urine (incomplete bladder emptying).

      • Increased glucose in the urine (e.g., diabetes).

      • Catheters.

    • Manifestations:

      • Classic Symptoms: Dysuria (painful urination), frequency, and urgency.

      • Physical Assessment: Suprapubic pain upon palpation.

      • Urine: Smelly or cloudy.

      • Urinalysis (UA) Findings: Positive for White Blood Cells (WBCs) and Nitrites.

  • Pyelonephritis

    • Pathophysiology: Bacteria ascend further beyond the bladder to infect the kidneys.

    • Complications: Can lead to Urosepsis, kidney scarring (potential renal failure), and abscess formation.

Obstructive Processes

  • Kidney Stones (Nephrolithiasis)

    • Pathophysiology: Urine becomes too concentrated with solutes for them to stay in solution, leading to crystal formation and growth.

    • Types of Stones:

      • Calcium Oxalate: Accounts for approximately 80%80\% of all stones.

      • Uric Acid Stones: Often associated with gout or obesity.

    • Risk Factors: Dehydration, high intake of sodium/animal protein/oxalate, and diseases like obesity, diabetes, and gout.

    • Manifestations: Severe flank or groin pain, hematuria, and painful urination.

    • Complications:

      • Damage to the urinary tract lining.

      • Urinary obstruction leading to infection or Pyelonephritis.

      • Hydronephrosis: Dilation of the renal pelvis and calyces which can lead to permanent kidney scarring and damage.

  • Benign Prostatic Hyperplasia (BPH)

    • Epidemiology: Very common, affecting approximately 70%70\% of men over age 60.

    • Symptoms: Difficulty starting urination, straining to void, and weak or slow urine flow.

    • Risk Factors: Age (> 40), family history, obesity, diabetes, and cardiovascular disease.

    • Complications:

      • Chronic: Recurrent UTIs, renal insufficiency, and persistent Lower Urinary Tract Symptoms (LUTS).

      • Acute: Sudden total loss of ability to void (Acute urinary retention) and acute bacterial prostatitis due to chronic inflammation.

Acute Kidney Injury (AKI)

  • Classification and Progression

    • Definition: Rapid onset of loss of function over a few hours or days. Mostly reversible but can result in metabolic acidosis.

  • Types of AKI

    • Pre-Renal (Most Common): Decrease in blood flow to the kidneys (e.g., hypovolemia, heart failure, shock).

      • Kidney Response: Activation of RAAS.

      • Labs: Decreased GFR, increased Creatinine and BUN. The BUN:Cr ratio is typically > 20:1 because BUN is reabsorbed passively with water while Creatinine is strictly filtered.

    • Intra-Renal: Direct damage to kidney tissue.

      • Etiologies: Acute Tubular Necrosis (ATN), Glomerulonephritis, Pyelonephritis, toxins (contrast dye), or ischemia.

      • Labs: BUN:Cr ratio < 20:1. Low urine concentration, high urine sodium.

    • Post-Renal: Obstruction of urine flow (e.g., stones, BPH, tumors, spinal cord injury).

      • Labs: BUN:Cr ratio < 20:1.

  • Acute Tubular Necrosis (ATN)

    • The primary pathological process within intra-renal AKI.

    • Etiologies: Ischemic (shock, HUS) or toxic (myoglobin from rhabdomyolysis, drugs, dyes).

    • Diagnostic Clue: Urinalysis shows muddy brown granular casts.

    • Prognosis: Tubular cells can regrow if treated quickly.

  • Phases of AKI

    • Initiation Phase: Initial injury occurs but symptoms aren't yet noticeable.

    • Oliguric Phase: Urine output drops below 400 mL/day400\,mL/day. BUN/Cr rise and hyperkalemia may develop. This is the most dangerous phase, lasting days to weeks.

    • Diuretic Phase: Tubular function begins to recover. Urine output increases (sometimes massively). Risk of dehydration as the kidneys cannot yet concentrate urine.

    • Recovery Phase: GFR normalizes; this can take months.

Chronic Kidney Disease (CKD)

  • Definition and Classification

    • Definition: Progressive, irreversible loss of function. Defined as GFR < 60\,mL/min for 33 months or more.

    • Groups:

      • Group 1 (Stages G1-G2): Damage present but GFR is normal to mildly reduced (≥60\ge 60).

      • Group 2 (Stages G3a-G4): CKD without kidney failure (15−5915-59). Complications begin to appear.

      • Group 3 (Stage G5): Kidney failure/ESRD (GFR < 15). Requires dialysis or transplant.

  • Complications of CKD

    • Anemia: Decreased EPO production. Classified as Anemia of Chronic Disease (ACD); typically Normocytic/Normochromic.

    • CKD-Mineral and Bone Disorder (CKD-MBD):

      1. Decrease in active Vitamin D leads to low calcium absorption (Hypocalcemia).

      2. Hypocalcemia triggers Secondary Hyperparathyroidism (PTH pulls calcium from bones).

      3. Failure to excrete phosphate leads to Hyperphosphatemia, which binds calcium and creates insoluble complexes.

      4. Manifestations: Renal Osteodystrophy (bone pain, fractures), vascular calcification, and soft tissue calcium deposits.

    • Cardiovascular Disease:

      • Kidneys cannot excrete water/sodium, leading to volume expansion and hypertension.

      • CKD patients have a 2.5−3×2.5-3\times higher risk of CVD mortality at stage 3b. 40%−50%40\%-50\% of CKD patients die from CVD.

    • Electrolyte/Acid-Base Imbalances:

      • Hyperkalemia: Life-threatening; 90%90\% of potassium is usually excreted by the kidneys.

      • Metabolic Acidosis: Inability to excrete the daily load of acid.

    • Uremia: Build-up of nitrogenous waste (Urea).

      • Complications: Uremic Encephalopathy (confusion), Uremic Pericarditis (can lead to cardiac tamponade).

      • Physical signs: Intense itching (pruritus), nausea, and Uremic Frost (urea crystals on the skin).

  • Management Concepts

    • Renal Replacement Therapy: Hemodialysis, peritoneal dialysis, or transplant.

    • Dietary Restrictions: Protein (moderate restriction in Group 2), Sodium, Potassium, Phosphate, and Fluid (especially in late stages).